The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

According to Coherent Market Insights (CMI), the global protein therapeutics market size is projected to expand at a CAGR of ...

The CDSCO's expert panel consented for firm's proposal for discontinuation of products noting that alternative therapies are ...

A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are encapsulated into recombinant adeno-associated virus (rAAV) capsids as ...

With the aim of streamlining the regulatory process for biopharmaceutical manufacturers engaged in vaccine, recombinant DNA, ...

The AI2Health cluster of the Ken Kennedy Institute and the Synthetic Biology Institute at Rice University hosted a debriefing and collaborative discussion session on the Spirit of Asilomar summit June ...

Whether it’s cancer, diabetes, or Alzheimer’s disease — badly behaved proteins are behind dozens of the most devastating diseases. If our bodies are an orchestra, proteins are our maestros. As ...